Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer
Sofia Agelaki(University of Crete), Vassilis Georgoulias(Hellenic Oncology Research Group)
Cited by 58
Related Papers
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
|Breast Cancer Research|2011|373
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer
|ESMO Open|2021|93
Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer
|Cancers|2020|88
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
|Cancer Immunology Immunotherapy|2021|39